Characteristic | LOS < 7 days (n = 1435) | LOS ≥ 7 days (n = 1619) | P value |
---|---|---|---|
Demographics | |||
Age, mean (SD), y | 67.8 (11.9) | 70.8 (12.0) | < 0.001 |
Female | 538 (37.5) | 705 (43.6) | 0.001 |
NIHSS at admission | < 0.001 | ||
≤ 5 | 1003 (69.9) | 553 (34.2) | |
6–10 | 290 (20.2) | 421 (26.0) | |
11–15 | 49 (3.4) | 205 (12.7) | |
16–20 | 32 (2.2) | 163 (10.1) | |
> 20 | 61 (4.3) | 277 (17.1) | |
Median (IQR) | 4 (2-6) | 8 (4-16) | < 0.001 |
Stroke mechanism | < 0.001 | ||
Large artery atherosclerosis | 252 (17.6) | 515 (31.8) | |
Cardioembolism | 127 (8.9) | 303 (18.7) | |
Small-vessel occlusion | 717 (50.0) | 397 (24.5) | |
Specific etiology | 11 (0.8) | 30 (1.9) | |
Undetermined etiology | 328 (22.9) | 374 (23.1) | |
Medical conditions | |||
Hypertension | 1133 (79.0) | 1328 (82.0) | 0.032 |
Diabetes mellitus | 584 (40.7) | 750 (46.3) | 0.002 |
Hyperlipidemia | 837 (58.3) | 883 (54.5) | 0.035 |
Prior stroke | 380 (26.5) | 547 (33.8) | < 0.001 |
Atrial fibrillation | 188 (13.1) | 372 (23.0) | < 0.001 |
Coronary heart disease | 176 (12.3) | 241 (14.9) | 0.035 |
Congestive heart failure | 56 (3.9) | 118 (7.3) | < 0.001 |
Malignancy | 75 (5.2) | 111 (6.9) | 0.060 |
Uremia on dialysis | 22 (1.5) | 36 (2.2) | 0.163 |
Current smoker | 369 (25.7) | 351 (21.7) | 0.009 |
Dependent (mRS ≥ 3) before admission | 107 (7.5) | 266 (16.4) | < 0.001 |
Prior medication use | |||
Antiplatelet | 352 (24.5) | 446 (27.6) | 0.058 |
Oral anticoagulant | 38 (2.7) | 49 (3.0) | 0.530 |
Leukocytosis (> 10 × 109 cells/L) at admission | 215 (15.0) | 398 (24.6) | < 0.001 |
Intravenous thrombolysis | 83 (5.8) | 123 (7.6) | 0.046 |
Complications | |||
Pneumonia | 16 (1.1) | 239 (14.8) | < 0.001 |
Urinary tract infection | 35 (2.4) | 212 (13.1) | < 0.001 |
Upper gastrointestinal bleeding | 22 (1.5) | 171 (10.6) | < 0.001 |
Symptomatic intracerebral hemorrhage | 4 (0.3) | 37 (2.3) | < 0.001 |
mRS ≥ 3 at discharge | 488 (34.0) | 1279 (79) | < 0.001 |
Mortality at discharge | 46 (3.2) | 45 (2.8) | 0.489 |